Increased Expression of CTLA-4 in Malignant T Cells from Patients with Mycosis Fungoides – Cutaneous T-Cell Lymphoma

This publication has 38 references indexed in Scilit:

• Mycosis fungoides and the Sézary syndrome
  Current Opinion in Oncology, 2004
• CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm
  Journal of Allergy and Clinical Immunology, 2004
• Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
  Nature, 2003
• Current Concepts of the Immunobiology and Immunotherapy of Cutaneous T Cell Lymphoma: Insights Gained through Cross-talk between the Clinic and the Bench
  Leukemia & Lymphoma, 2003
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
  The Journal of Experimental Medicine, 2001
• CTLA4 ligation attenuates AP-1, NFAT and NF-κB activity in activated T cells
  European Journal of Immunology, 1999
• The Emerging Role of CTLA-4 as an Immune Attenuator
  Immunity, 1997
• Th2 Cytokine Profile in Cutaneous T-Cell Lymphoma
  Journal of Investigative Dermatology, 1995
• Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment
  CA: A Cancer Journal for Clinicians, 1993